$3120
Article publishing charge
for open access
12 days
Time to first decision
69 days
Review time
63 days
Submission to acceptance
Editor-in-Chief
View full editorial boardArticles
EditorialNo accessMarch–April 2024
https://doi.org/10.1016/j.therap.2023.10.007
Research articleAbstract onlyMarch–April 2024
https://doi.org/10.1016/j.therap.2023.09.009
Research articleAbstract onlyMarch–April 2024
https://doi.org/10.1016/j.therap.2023.10.008
Research articleAbstract onlyMarch–April 2024
https://doi.org/10.1016/j.therap.2023.09.007
Research articleAbstract onlyMarch–April 2024
https://doi.org/10.1016/j.therap.2023.09.008
Research articleAbstract onlyMarch–April 2024
https://doi.org/10.1016/j.therap.2023.11.003
Research articleAbstract onlyMarch–April 2024
https://doi.org/10.1016/j.therap.2023.10.009
Research articleAbstract onlyMarch–April 2024
https://doi.org/10.1016/j.therap.2023.11.002
More from Therapies
Special issues and article collections
Drugs induced diseases
March–April 2024
GIENS WORKSHOPS 2023
January–February 2024
Numéro supplément "Varia"
September–October 2023
Recent advances in pharmacovigilance and pharmacoepidemiology
September–October 2023
Print ISSN: 0040-5957
Online ISSN: 1958-5578
Copyright © 2024 Société Française de Pharmacologie et de Thérapeutique. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.